Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Diabetes|July 19, 2013
Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlatesRalph A Defronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Diabetes Care|September 25, 2013
Prediction of diabetes based on baseline metabolic characteristics in individuals at high riskRalph A Defronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Diabetes Care|June 16, 2018
Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary SyndromeIlse C Schrieks, Anna Nozza, Barbara E Stähli, et al.
Age (Dordrecht, Netherlands)|September 3, 2016
Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose toleranceSara E Espinoza, Chen-Pin Wang, Devjit Tripathy, et al.
Diabetes Care|June 21, 2014
Basal insulin peglispro demonstrates preferential hepatic versus peripheral action relative to insulin glargine in healthy subjectsRobert R Henry, Sunder Mudaliar, Theodore P Ciaraldi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2013
Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrierAjit S Divakaruni, Sandra E Wiley, George W Rogers, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 24, 2012
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factorsAramesh Saremi, Dawn C Schwenke, Thomas A Buchanan, et al.
The New England Journal of Medicine|March 25, 2011
Pioglitazone for diabetes prevention in impaired glucose toleranceRalph A DeFronzo, Devjit Tripathy, Dawn C Schwenke, et al.
JCI Insight|November 23, 2021
p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytesVitor F Martins, Samuel A LaBarge, Alexandra Stanley, et al.
The Journal of Clinical Endocrinology and Metabolism|January 21, 2015
A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW studyDevjit Tripathy, Jeff E Cobb, Walter Gall, et al.
Pageof 15